Medeon Biodesign Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-668.06	-805.51	-1,205	-433.76	2,078
Depreciation & Amortization	105.37	96.69	93.62	61.77	58.02
Other Amortization	1.99	1.98	2.05	2.03	0.99
Loss (Gain) From Sale of Assets	-	-	13.01	-	-
Loss (Gain) From Sale of Investments	-1.72	2.28	399.15	-0.68	-2,507
Loss (Gain) on Equity Investments	-	-	-13.54	-47.69	-19.66
Stock-Based Compensation	13.68	9.73	15.69	3.11	5.95
Provision & Write-off of Bad Debts	0.07	13.41	0.58	-	-0.36
Other Operating Activities	-50.48	-145.65	-89.68	-76.96	-2,607
Change in Accounts Receivable	-0.95	-9.47	-9.99	5.3	39.65
Change in Inventory	9.26	-23.33	-0.71	-4.4	-10.04
Change in Accounts Payable	-4.45	6.64	1.42	2.87	4.42
Change in Unearned Revenue	3.42	1.41	2.25	0.21	-8.18
Change in Other Net Operating Assets	-37.28	19.18	35.7	26.86	36.56
Operating Cash Flow	-629.14	-832.67	-755.08	-461.34	-293.38
Capital Expenditures	-16.47	-74.3	-55.29	-140.57	-8.32
Cash Acquisitions	-	-	-	-165.89	4.21
Divestitures	-	-	-	-	450.92
Sale (Purchase) of Intangibles	-0.41	-0.47	-0.52	-0.15	-0.7
Investment in Securities	-4.78	209.92	1,643	552.91	-535.92
Other Investing Activities	0.16	0.06	8.64	17.13	-0.83
Investing Cash Flow	-21.5	135.21	1,596	263.44	-90.64
Long-Term Debt Repaid	-52.89	-50.53	-47.89	-29.17	-17.4
Total Debt Repaid	-52.89	-50.53	-47.89	-29.17	-17.4
Net Debt Issued (Repaid)	-52.89	-50.53	-47.89	-29.17	-17.4
Issuance of Common Stock	3.77	3.85	0.23	-	10.1
Common Dividends Paid	-	-	-43.82	-73.03	-
Other Financing Activities	717.11	-	0.91	1.05	3.4
Financing Cash Flow	667.98	-46.68	-90.57	-101.16	-3.9
Foreign Exchange Rate Adjustments	-9.94	19.55	4.09	47.64	-4.89
Net Cash Flow	7.41	-724.59	754.07	-251.42	-392.81
Free Cash Flow	-645.61	-906.97	-810.36	-601.91	-301.69
Free Cash Flow Margin	-153.93%	-309.75%	-412.90%	-201.77%	-437.51%
Free Cash Flow Per Share	-6.99	-9.84	-8.80	-6.54	-3.28
Cash Interest Paid	3.64	5.56	6.64	4.6	1.55
Cash Income Tax Paid	2.31	86.81	59.94	69.21	4.35
Levered Free Cash Flow	-383.52	-561.07	-455.87	-416.46	-89.12
Unlevered Free Cash Flow	-381.22	-557.6	-451.72	-413.2	-88.48
Change in Working Capital	-29.99	-5.59	28.67	30.84	62.4

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.